Gastroenterologische Praxis Balsiger, Seibold & Partner

Bern, Canton of Bern 3012

0 studies enrolling now · 2 studies all time

What they study most

Crohn's Disease, Ulcerative Colitis

Studies at this site

• A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
• A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Running, not enrolling